The global veterinary pain management market size was estimated at USD 1.15 billion in 2018 and is expected to witness a CAGR of +5.3% during the forecast period. 

Pet Pain Management Drugs market increasing incidence of pet obesity is further fueling the veterinary pain management market. According to the Association for Pet Obesity Prevention (APOP) in 2017, 56% dogs and 59% cats were recorded as obese in U.S. Obesity increases the risk of joint diseases, diabetes mellitus, cancer and other chronic conditions. Furthermore, according to kingsbrookvets, in 2017, 20% of all pet dogs in U.S. had osteoarthritis regardless of their age. Obesity also increases the risk of cancer in canines.

Rise in initiatives by government organizations to promote animal health globally, is expected to contribute to the market growth. For instance, in 2016 the European government invested USD 4.7 million in animal healthcare expenditure according to a report by the European External Action Service (EEAS). In January 2016, central state government of India raised the import duty on veterinary products from 5% to 7.5% in an attempt to boost in pharmaceutical manufacturing and the Make in India campaign.

For Sample Copy of the report:

Some of the leading key players profiled in this study:

Boehringer Ingelheim, Zoetis, Inc. , Merck Animal Health , Elanco , Bayer AG, Vetoquinol S.A., Ceva Sante Animale, Virbac Group, Norbrook Laboratories Ltd, Dechra Pharmaceuticals and other key players .

The report can effectively help companies and decision makers in addressing these challenges strategically to gain the maximum benefits in the highly competitive Pet Pain Management Drugs market. Data pertaining to the recent product and technological developments observed in the market, complete with an analysis of the impact of these advancements on the market’s future development is included in the report.

Avail Discount at:

The report also presents a 360-degree overview of the competitive scenario of the global Pet Pain Management Drugs market, thus helping organizations understand the major threat and opportunities that vendors in the market are dealt with and includes detailed business profiles of some of the major vendors in the market. Also, the report offers a SWOT analysis of the global market. This report gives a clear picture of the Pet Pain Management Drugs market scenario for the better understanding to the readers.

Different approaches are used to analyze each and every application segment of Pet Pain Management Drugs domain. Competitive landscape mapped by considering some of the factors, such as product and technology. Finally, it focuses on the ways to define the frameworks, which helps to identify the various platforms for opportunities. Different driving factors are mentioned with in-depth analysis of Pet Pain Management Drugs market. In addition to this, it elaborates the restraint factors, to gives a clear picture of challenging threat in front of the industries.

For More Information:

Table of Content (TOC):

Chapter 1 Pet Pain Management Drugs Market Overview

Chapter 2 Market Competition by Manufacturers

Chapter 3 Production, Revenue (Value) by Region

Chapter 4 Supply (Production), Consumption, Export, Import by Regions

Chapter 5 Production, Revenue (Value), Price Trend by Type

Chapter 6 Pet Pain Management Drugs Market Analysis by Application

Chapter 7 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 8 Marketing Strategy Analysis, Distributors/Traders

Chapter 9 Market Effect Factors Analysis

Chapter 10 Pet Pain Management Drugs Market Forecast

Chapter 11 Research Findings and Conclusion

About Us:

At HealthCare Intelligence Markets

Contact Us:

Address: 90, State Office Center,

90, State Street Suite 700,

Albany, NY 12207



Phone: +1 (888) 616-2766